Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...

The FDA resolved the shortage of Eli Lilly's tirzepatide, but may revisit allowing compounding pharmacies to make copies, ...

Weight-loss drug Wegovy will go on sale in Korea on Tuesday, with the much-anticipated injectable drug available for order ...

Mounjaro, the brand name for tirzepatide, is a drug that treats type 2 diabetes by lowering blood sugar levels. According to ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.